Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 03-Apr-24 6:16 PM View:  | Avidity Biosciences, Inc. (RNA) | 02-Apr-24 | Option Exercise | 28,000 | $1.24 | $34,720.00 | 25% 112.12K to 140.12K | |
| 03-Apr-24 6:16 PM View: | Avidity Biosciences, Inc. (RNA) | 02-Apr-24 | Option Sale | 28,000 | $26.25 | $734,919.00 | (20%) 140.12K to 112.12K | |
| 12-Mar-24 5:29 PM View: | Avidity Biosciences, Inc. (RNA) | 12-Mar-24 | Option Exercise | 28,000 | $1.24 | $34,720.00 | 25% 112.12K to 140.12K | |
| 12-Mar-24 5:29 PM View: | Avidity Biosciences, Inc. (RNA) | 12-Mar-24 | Option Sale | 28,000 | $22.63 | $633,682.00 | (20%) 140.12K to 112.12K | |
| 12-Mar-24 5:29 PM View: | Avidity Biosciences, Inc. (RNA) | 08-Mar-24 | Option Exercise | 84,000 | $1.24 | $104,160.00 | 75% 112.12K to 196.12K | |
| 12-Mar-24 5:29 PM View: | Avidity Biosciences, Inc. (RNA) | 08-Mar-24 | Option Sale | 84,000 | $21.39 | $1,796,710.00 | (43%) 196.12K to 112.12K | |
| 05-Mar-24 4:53 PM View: | Avidity Biosciences, Inc. (RNA) | 01-Mar-24 | Option Exercise | 84,000 | $1.24 | $104,160.00 | 75% 112.12K to 196.12K | |
| 05-Mar-24 4:53 PM View: | Avidity Biosciences, Inc. (RNA) | 01-Mar-24 | Option Sale | 84,000 | $20.13 | $1,691,310.00 | (43%) 196.12K to 112.12K | |
| 23-Jan-24 3:13 PM View: | Avidity Biosciences, Inc. (RNA) | 22-Jan-24 | Sale (Planned) | 5,092 | $10.13 | $51,582.00 | (10%) 49.1K to 44.01K | |
| 23-Jan-24 3:13 PM View: | Avidity Biosciences, Inc. (RNA) | 20-Jan-24 | Grant | 62,500 | -- | -- | 1327% 4.71K to 67.21K | |
| 03-Feb-23 5:26 PM View: | Avidity Biosciences, Inc. (RNA) | 03-Feb-23 | Option Exercise | 3,221 | $1.24 | $3,994.04 | 6% 53.35K to 56.57K | |
| 03-Feb-23 5:26 PM View: | Avidity Biosciences, Inc. (RNA) | 03-Feb-23 | Planned Option Sale | 3,221 | $24.26 | $78,141.50 | (6%) 56.57K to 53.35K | |
| 03-Feb-23 5:26 PM View: | Avidity Biosciences, Inc. (RNA) | 02-Feb-23 | Option Exercise | 45,879 | $1.24 | $56,890.00 | 86% 53.35K to 99.23K | |
| 03-Feb-23 5:26 PM View: | Avidity Biosciences, Inc. (RNA) | 02-Feb-23 | Planned Option Sale | 45,879 | $24.36 | $1,117,740.00 | (46%) 99.23K to 53.35K | |
| 03-Feb-23 5:26 PM View: | Avidity Biosciences, Inc. (RNA) | 01-Feb-23 | Option Exercise | 900 | $1.24 | $1,116.00 | 2% 53.35K to 54.25K | |
| 03-Feb-23 5:26 PM View: | Avidity Biosciences, Inc. (RNA) | 01-Feb-23 | Planned Option Sale | 900 | $24.27 | $21,844.40 | (2%) 54.25K to 53.35K | |
| 01-Feb-23 2:10 PM View: | Omniab, Inc. (OABI) | 30-Jan-23 | Grant | 8,753 | -- | -- | 12% 73.44K to 82.19K | |
| 24-Jan-23 9:13 PM View: | Avidity Biosciences, Inc. (RNA) | 20-Jan-23 | Grant | 50,000 | -- | -- | 1492% 3.35K to 53.35K | |
| 14-Nov-22 4:30 PM View: | Omniab, Inc. (OABI) | 10-Nov-22 | Purchase | 15,000 | $2.92 | $43,800.00 | 20% 73.44K to 88.44K | |
| 14-Nov-22 4:30 PM View: | Omniab, Inc. (OABI) | 09-Nov-22 | Purchase | 21,000 | $2.74 | $57,596.70 | 40% 52.44K to 73.44K | |
| 03-Nov-22 9:06 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 01-Nov-22 | Disposition | 1,004 | -- | -- | (26%) 3.9K to 2.89K | |
| 03-Nov-22 9:15 PM View: | Omniab, Inc. (OABI) | 01-Nov-22 | Grant | 37,437 | -- | -- | 100% 0 to 37.44K | |
| 26-Aug-22 7:29 PM View: | Avidity Biosciences, Inc. (RNA) | 25-Aug-22 | Option Exercise | 14,855 | $1.24 | $18,420.20 | 100% 0 to 14.86K | |
| 26-Aug-22 7:29 PM View: | Avidity Biosciences, Inc. (RNA) | 25-Aug-22 | Planned Option Sale | 14,855 | $23.07 | $342,690.00 | (100%) 14.86K to 0 | |
| 26-Aug-22 7:29 PM View: | Avidity Biosciences, Inc. (RNA) | 24-Aug-22 | Option Exercise | 35,045 | $1.24 | $43,455.80 | 100% 0 to 35.05K | |
| 26-Aug-22 7:29 PM View: | Avidity Biosciences, Inc. (RNA) | 24-Aug-22 | Planned Option Sale | 35,045 | $22.80 | $798,924.00 | (100%) 35.05K to 0 | |
| 17-Aug-22 9:40 PM View: | Avidity Biosciences, Inc. (RNA) | 15-Aug-22 | Option Exercise | 100 | $1.24 | $124.00 | 100% 0 to 100 | |
| 17-Aug-22 9:40 PM View: | Avidity Biosciences, Inc. (RNA) | 15-Aug-22 | Planned Option Sale | 100 | $22.47 | $2,247.00 | (100%) 100 to 0 | |
| 13-Jun-22 6:47 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 10-Jun-22 | Grant | 1,004 | -- | -- | 35% 2.89K to 3.9K | |
| 07-Jun-21 9:25 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 04-Jun-21 | Grant | 630 | -- | -- | 28% 2.26K to 2.89K | |
| 18-May-21 9:46 PM View: | Bruker Cellular Analysis, I... (CELL) | 14-May-21 | Grant | 1,400 | -- | -- | 100% 0 to 1.4K | |
| 03-Mar-21 9:22 PM View: | Bruker Cellular Analysis, I... (CELL) | 01-Mar-21 | Option Exercise | 10,000 | $8.90 | $89,000.00 | 100% 0 to 10.0K | |
| 03-Mar-21 9:22 PM View: | Bruker Cellular Analysis, I... (CELL) | 01-Mar-21 | Market Option Sale (Planned) | 10,000 | $61.13 | $611,337.00 | (100%) 10.0K to 0 | |
| 12-Jun-20 6:35 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 10-Jun-20 | Grant | 831 | -- | -- | 58% 1.43K to 2.26K | |
| 16-Oct-19 6:01 PM View: | Ligand Pharmaceuticals Inc. (LGND) | 15-Oct-19 | Grant | 1,431 | -- | -- | 100% 0 to 1.43K | |
| 17-Jul-19 4:52 PM View: | Akcea Therapeutics, Inc. (AKCA) | 15-Jul-19 | Market Sale | 1,819 | $23.52 | $42,782.90 | (8%) 21.71K to 19.89K | 3% |
| 03-Jul-19 4:31 PM View: | Akcea Therapeutics, Inc. (AKCA) | 01-Jul-19 | Grant | 813 | $20.04 | $16,295.00 | 4% 20.89K to 21.71K | |
| 18-Apr-18 1:00 PM View: | Akcea Therapeutics, Inc. (AKCA) | 17-Apr-18 | Grant | 20,894 | -- | -- | 100% 0 to 20.89K | |
| 17-Jan-18 9:23 PM View: | ISIS Pharmaceuticals Inc. (IONS) | 16-Jan-18 | Market Option Sale | 2,196 | $51.76 | $113,665.00 | (20%) 11.13K to 8.93K | (15%) |
| 17-Jan-18 9:23 PM View: | ISIS Pharmaceuticals Inc. (IONS) | 15-Jan-18 | Option Exercise | 5,367 | -- | -- | 93% 5.76K to 11.13K | |
| 02-Jan-18 8:45 PM View: | ISIS Pharmaceuticals Inc. (IONS) | 01-Jan-18 | Acquisition (other) | 491 | $42.76 | $20,992.70 | 9% 5.27K to 5.76K | |
| 03-Jul-17 5:35 PM View: | ISIS Pharmaceuticals Inc. (IONS) | 01-Jul-17 | Acquisition (other) | 17 | $40.66 | $691.14 | < 1% 5.25K to 5.27K | |
| 18-Jan-17 6:48 PM View: | ISIS Pharmaceuticals Inc. (IONS) | 17-Jan-17 | Market Option Sale | 1,361 | $46.29 | $63,000.70 | (21%) 6.61K to 5.25K | (29%) |
| 18-Jan-17 6:48 PM View: | ISIS Pharmaceuticals Inc. (IONS) | 15-Jan-17 | Option Exercise | 3,483 | -- | -- | 153% 2.27K to 5.76K | |
| 04-Jan-17 6:35 PM View: | ISIS Pharmaceuticals Inc. (IONS) | 01-Jan-17 | Acquisition (other) | 992 | $20.76 | $20,590.90 | 46% 2.14K to 3.13K | |
| 01-Jul-16 8:18 PM View: | ISIS Pharmaceuticals Inc. (IONS) | 01-Jul-16 | Acquisition (other) | 403 | $20.76 | $8,365.07 | 23% 1.74K to 2.14K | |
| 19-Jan-16 8:08 PM View: | ISIS Pharmaceuticals Inc. (IONS) | 19-Jan-16 | Market Option Sale | 872 | $41.46 | $36,150.90 | (33%) 2.61K to 1.74K | (44%) |
| 19-Jan-16 8:08 PM View: | ISIS Pharmaceuticals Inc. (IONS) | 15-Jan-16 | Option Exercise | 2,188 | -- | -- | 522% 0.42K to 2.61K | |
| 04-Jan-16 9:21 PM View: | ISIS Pharmaceuticals Inc. (IONS) | 01-Jan-16 | Acquisition (other) | 419 | $47.71 | $19,990.70 | 100% 0 to 0.42K |